Eloxx Pharmaceuticals, Inc. (ELOX) Stock Price & Analysis
Eloxx Pharmaceuticals, Inc. (ELOX) rose 0.00% to USD 11.94 as of July 25, 2026 at 03:52 UTC, according to Nexqual real-time market data.
ELOX last closed at USD 11.94; the session ranged USD 11.45–12.41 on volume of 89,218 shares. Market capitalization is —, with a 52-week range of USD 8.2–17.5 (NCM). Source: Nexqual, July 25, 2026 at 03:52 UTC.
Key Statistics (as of July 25, 2026 at 03:52 UTC)
| Price | USD 11.94 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.94 |
| Open | USD 11.94 |
| Day Range | USD 11.45 – 12.41 |
| 52-Week Range | USD 8.2 – 17.5 |
| Volume | 89,218 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ELOX)
Nexqual's technical model rates ELOX "SELL" based on 0 bullish and 3 bearish signals across 32 daily candles, as of July 25, 2026 at 03:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 51.38 (neutral) |
| MACD | -0.22 (negative) |
From Eloxx Pharmaceuticals, Inc.'s Latest SEC 10-K Filing (filed 2026-03-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Even if we succeed in bringing one or more products to the market, these products may not be considered cost-effective, and the amount reimbursed for any products may be insufficient to allow us to sell our products on a competitive basis.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | USD 0 | ▲ 0% |
| CYCN | Cyclerion Therapeutics, Inc. | USD 3.5 | ▼ 3.58% |
| ATXI | Avenue Therapeutics, Inc. | USD 0.28 | ▲ 2.22% |
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| SYBX | Synlogic, Inc. | USD 0.67 | ▼ 5.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:52 UTC. This page is informational and not investment advice.